SXTC

China SXT Pharmaceuticals, Inc. Class A Ordinary Shares

SXTC
Closed
$2.54
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
Country

CN

CEO

Mr. Feng Zhou

IPO date

2019

Employees

75

ISIN

VGG2161P1650

Key stats

Open

$2.63

Volume

11.83K

Market cap

$81.51M

Prev. close

$2.52

Impl / hst vl

-

Open interest

$0.00

$2.50

Day’s Range

$2.63

$0.03

52W Range

$6.98

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
55.51
P/B
4.22
Current ratio
4.37
Debt / Equity
-0.99
ROE
-49.73%
Gross margin
16.23%
Income growth
154.64%
FCF growth
76.99

Analysts estimates

Earnings

Q3 ‘25 revenue
$626.60K
Q3 ‘25 net income
-$6.37M
Revenue
Net income
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply